Bioactivity:

The combination of Valproic acid with coumarin-3-carboxylic acid suppresses the proliferation and migration of lung cancer cells via EGFR/VEGFR2/c-Met-Akt-NF-_B signaling pathways; this combination may have a wide therapeutic and/or adjuvant therapeutic a

CAS nr:

531-81-7

Purity:

98%

Molecular Weight:

190,15

SMILES:

C1=CC=C2C(=C1)C=C(C(=O)O2)C(=O)O

Formula:

C10H6O4

Pathway:

Tyrosine Kinase/Adaptors,Angiogenesis

Target:

VEGFR,VEGFR